NexturnBioscience Co. Ltd Asset Resilience Ratio
NexturnBioscience Co. Ltd asset resilience ratio. NexturnBioscience Co. Ltd (089140) has an Asset Resilience Ratio of 8.09% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 089140 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of NexturnBioscience Co. Ltd (2014–2024)
Asset resilience ratio of NexturnBioscience Co. Ltd from 2014 to 2024. This chart shows how NexturnBioscience Co. Ltd's Asset Resilience Ratio has changed over time. Read NexturnBioscience Co. Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down NexturnBioscience Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see NexturnBioscience Co. Ltd asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩29.86 Billion | 8.09% |
| Total Liquid Assets | ₩29.86 Billion | 8.09% |
Asset Resilience Insights
- Limited Liquidity: NexturnBioscience Co. Ltd maintains only 8.09% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
NexturnBioscience Co. Ltd Industry Peers by Asset Resilience Ratio
Compare NexturnBioscience Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medivie Therapeutic Ltd
TA:MDVI |
Machinery, Tools, Heavy Vehicles, Trains & Ships | 0.76% |
|
SPG Co. Ltd
KQ:058610 |
Machinery, Tools, Heavy Vehicles, Trains & Ships | 0.98% |
|
BHI Co. Ltd
KQ:083650 |
Machinery, Tools, Heavy Vehicles, Trains & Ships | 1.11% |
|
Sungho Electronics Corp
KQ:043260 |
Machinery, Tools, Heavy Vehicles, Trains & Ships | 1.80% |
|
Woori Technology Inc
KQ:032820 |
Machinery, Tools, Heavy Vehicles, Trains & Ships | 0.38% |
|
Tae Kwang Corporation
KQ:023160 |
Machinery, Tools, Heavy Vehicles, Trains & Ships | 20.34% |
|
Samkang M&T Co.Ltd
KQ:100090 |
Machinery, Tools, Heavy Vehicles, Trains & Ships | 18.63% |
|
VITZROCELL Co.Ltd
KQ:082920 |
Machinery, Tools, Heavy Vehicles, Trains & Ships | 34.28% |
NexturnBioscience Co. Ltd Asset Resilience Ratio by Year (2014–2024)
NexturnBioscience Co. Ltd asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for NexturnBioscience Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 15.39% | ₩35.86 Billion ≈ $24.30 Million |
₩233.04 Billion ≈ $157.93 Million |
+2.63pp |
| 2023-12-31 | 12.76% | ₩31.13 Billion ≈ $21.10 Million |
₩243.99 Billion ≈ $165.35 Million |
-1.29pp |
| 2022-12-31 | 14.06% | ₩28.15 Billion ≈ $19.07 Million |
₩200.26 Billion ≈ $135.71 Million |
-15.58pp |
| 2021-12-31 | 29.64% | ₩41.18 Billion ≈ $27.91 Million |
₩138.95 Billion ≈ $94.16 Million |
-24.51pp |
| 2020-12-31 | 54.15% | ₩53.80 Billion ≈ $36.46 Million |
₩99.35 Billion ≈ $67.33 Million |
+1.18pp |
| 2019-12-31 | 52.97% | ₩55.71 Billion ≈ $37.76 Million |
₩105.17 Billion ≈ $71.27 Million |
-9.13pp |
| 2018-12-31 | 62.11% | ₩70.50 Billion ≈ $47.78 Million |
₩113.52 Billion ≈ $76.93 Million |
-6.08pp |
| 2017-12-31 | 68.19% | ₩64.61 Billion ≈ $43.79 Million |
₩94.75 Billion ≈ $64.21 Million |
-4.91pp |
| 2016-12-31 | 73.10% | ₩72.03 Billion ≈ $48.81 Million |
₩98.53 Billion ≈ $66.77 Million |
+58.04pp |
| 2015-12-31 | 15.06% | ₩5.00 Billion ≈ $3.39 Million |
₩33.21 Billion ≈ $22.51 Million |
+6.10pp |
| 2014-12-31 | 8.96% | ₩3.00 Billion ≈ $2.03 Million |
₩33.48 Billion ≈ $22.69 Million |
-- |
About NexturnBioscience Co. Ltd
Nexturn Co.,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. It provides CNC swiss-type automatic lathe products, high temperature display glass press equipment, and automatic line-up robots, as well as an intelligent intervention robot system based on robot 3D cardiovascular visualization technology. The company was formerly known as KMT Incorporated and chan… Read more